Crossmark Global Holdings’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8,431
Closed -$227K 1442
2021
Q3
$227K Sell
8,431
-10
-0.1% -$288 0.01% 1286
2021
Q2
$269K Sell
8,441
-20
-0.2% -$635 0.01% 1241
2021
Q1
$298K Buy
8,461
+660
+8% +$23K 0.01% 1172
2020
Q4
$250K Buy
+7,801
New +$240K 0.01% 1193
2018
Q4
Sell
-6,880
Closed -$227K 1515
2018
Q3
$227K Sell
6,880
-230
-3% -$8.6K 0.01% 1484
2018
Q2
$313K Buy
7,110
+410
+6% +$15.9K 0.01% 1277
2018
Q1
$280K Sell
6,700
-710
-10% -$32.8K 0.01% 1321
2017
Q4
$337K Buy
+7,410
New +$292K 0.01% 1299

Other funds holding PETS

Crossmark Global Holdings's PETS Position: Q4 2021 in Review

Crossmark Global Holdings sold out of PetMed Express (PETS) in Q4 2021, closing a stake of 8,431 shares — an estimated $227K sold.

Crossmark Global Holdings first reported a position in PETS in Q4 2017 and held it in 8 quarters. The position peaked at $337K in Q4 2017. 182 funds tracked by Wall St. Rank hold PETS as of Q4 2021.

  • Crossmark Global Holdings reported no remaining PetMed Express position as of Q4 2021 after selling out during the quarter.
  • Crossmark Global Holdings sold 8,431 PetMed Express shares in Q4 2021, an estimated $227K.
  • Crossmark Global Holdings first reported a position in PetMed Express in Q4 2017 and held it in 8 quarters.
  • Crossmark Global Holdings's PetMed Express position peaked at $337K in Q4 2017.
  • 182 funds tracked by Wall St. Rank held PetMed Express as of Q4 2021.

Based on Crossmark Global Holdings's 13F filing for Q4 2021, filed 10 Jan 2022.